Sawai Pharmaceutical: sales revenue

In the fiscal year 2021, the sales revenue of Sawai Pharmaceutical Co., Ltd. amounted to roughly 193.8 billion Japanese yen, the highest amount of the past decade. Within the observed period, figures increased steadily with each year.
Founded in 1929, Sawai is one of the leading manufacturers of generic pharmaceutical products in Japan.

Sales revenue of Sawai Pharmaceutical Co., Ltd. from fiscal year 2012 to 2021 (in billion Japanese yen)

Characteristic	Net sales in billion Japanese yen
2021	193.82
2020	187.22
2019	182.54
2018	184.34
2017	168.07
2016	132.39
2015	123.49
2014	105.45
2013	89.82
2012	80.5

Loading statistic...

Download

Source

Show detailed source information?

Already a member?

Source

Use Ask Statista Research Service

Release date

October 2022

More information

Region

Japan

Survey time period

fiscal years 2012 to 2021; the company’s fiscal year starts on April 1 of the stated year and ends on March 31 of the following year

Special properties

consolidated data

Supplementary notes

The Company has adopted International Financial Reporting Standards (IFRS) from the fiscal year 2017 onwards.

100 Japanese yen equal 0.73 U.S. dollars or 0.69 euros as of March 2023.
Figures have been rounded.

Citation formats